what statement(s) are true concerning analgesic use in patients with non-ST elevation ACS?

phosphodiesterase inhibitor can be used along with nitrates for continued ischemic chest pain
NSAID as ibuprofen can be used for continued ischemic chest pain
Zofran 8 mg ODT may be used for continued ischemic chest pain
IV morphine sulfate can be used for continued ischemic chest pain

what statement(s) are true concerning beta blockers use in patients with non-ST elevation ACS?

it is reasonable to continue beta blocker medication in patients with normal LV function with non-ST elevation ACS
in patients with risk factor for shock, IV metoprolol 10 mg can be given to reduce mortality
in patients with reduced systolic function, stable HF and non-ST elevation ACS, it is recommended to continue one of the three beta blockers that have been shown to reduce mortality: metoprolol succinate SR, bisoprolol or carvedilol.
oral beta blocker ought to be started within the initial 24 hours in the patient does have signs of HF,risk for cardiogenic shock, or other contraindications to beta blockage.

a 67-year-old African-American male presented to the ED with acute chest pain. With following recommendations are true regarding cardiac biomarkers?

obtain cardiac specific troponin ( troponin 1 or T) on presentation and then 3-6 hours following onset of symptoms
troponin elevations are helpful for only short term prognosis
BNP may be helpful also for prognostic information
collect additional troponin levels after six hours in those patients with initially normal troponins but with ECG changes and/or high risk clinical indicators
CK-MB and Myobloblin along with contemporary troponin assay are useful in diagnosing acute coronary syndrome